# GPR17

## Overview
GPR17 is a gene that encodes the G protein-coupled receptor 17, a member of the G protein-coupled receptor (GPCR) family, which is characterized by its seven transmembrane domains. This receptor is primarily expressed in oligodendrocyte precursor cells (OPCs) within the central nervous system, where it plays a pivotal role in the differentiation and maturation of these cells into oligodendrocytes, essential for myelination processes (Fumagalli2017Pharmacological; Lecca2020Regulation). GPR17 is activated by uracil nucleotides and cysteinyl-leukotrienes, influencing intracellular signaling pathways that are crucial for cellular development and function (Pugliese2009Functional; Lecca2020Regulation). Beyond its role in myelination, GPR17 is implicated in various physiological processes, including the regulation of food intake and neuroinflammatory responses, making it a significant target for research in metabolic and neurological disorders (Daniele2022Functional; Lecca2020Regulation).

## Structure
The GPR17 protein is a G protein-coupled receptor (GPCR) characterized by its seven transmembrane helices, a common feature of class-A GPCRs (Saravanan2018Identification). The primary structure of GPR17 consists of 339 amino acid residues (Saravanan2018Identification). The secondary structure is predominantly helical, as typical for GPCRs, with the transmembrane domains forming the core of the protein's structure (Saravanan2018Identification).

In terms of tertiary structure, GPR17's 3D conformation has been modeled using homology modeling techniques due to the absence of an experimentally resolved structure at the time of some studies. The model was validated using various computational tools, ensuring its reliability (Saravanan2018Identification). The tertiary structure includes specific binding sites identified through computational methods, with residues such as I178, L179, and R183 playing key roles in ligand interaction (Saravanan2018Identification).

GPR17 also forms quaternary structures, predominantly existing as dimers or higher-order oligomers in cellular environments. This dimerization involves transmembrane helices, particularly TM5, with residues like F229 and F233 being crucial for maintaining the dimer interface (Yang2020FLIM–FRETBased). The dimerization is stable and can be modulated by specific mutations, which affect the receptor's signaling functions (Yang2020FLIM–FRETBased).

## Function
GPR17 is a G protein-coupled receptor predominantly expressed in oligodendrocyte precursor cells (OPCs) within the central nervous system. It plays a crucial role in the differentiation and maturation of these cells into mature oligodendrocytes, which are essential for myelination (Fumagalli2017Pharmacological; Lecca2020Regulation). GPR17 expression is tightly regulated during oligodendrocyte development, initially promoting differentiation in early OPCs but inhibiting maturation in later stages. This regulation ensures proper timing of myelination, as GPR17 acts as a cell-intrinsic timer that delays myelination to allow for necessary metabolic changes (Fumagalli2017Pharmacological; Chen2009The).

Molecularly, GPR17 is activated by uracil nucleotides and cysteinyl-leukotrienes, which influence intracellular signaling pathways, including the modulation of delayed rectifier K+ currents in OPCs (Pugliese2009Functional; Lecca2020Regulation). This receptor's activation leads to changes in intracellular cAMP levels, which are crucial for the transition from OPCs to mature oligodendrocytes (Lecca2020Regulation). GPR17's expression is downregulated as cells mature, allowing for the completion of the myelination process (Fumagalli2017Pharmacological). The receptor's activity is also linked to the regulation of food intake through hypothalamic neuronal activities, highlighting its diverse roles in cellular and organismal physiology (Lecca2020Regulation).

## Clinical Significance
Mutations and alterations in the GPR17 gene are associated with several diseases and conditions. In metabolic diseases, such as obesity and type 2 diabetes, GPR17 missense variants have been identified with distinct downstream signaling profiles that may impact metabolic functions like feeding behavior and glucose homeostasis. These variants are rare, complicating genetic association analyses, but they suggest a potential contribution to metabolic derangements (Conley2021Human).

In neurological disorders, GPR17 is implicated in conditions like multiple sclerosis (MS) and traumatic brain injury. Altered expression of GPR17 is observed in demyelinating diseases, where it is upregulated in lesions, potentially contributing to remyelination failure by inhibiting oligodendrocyte differentiation (Chen2009The; Lecca2020Regulation). GPR17's role in oligodendrocyte dysfunction is also noted in amyotrophic lateral sclerosis (ALS), where its upregulation impairs oligodendrocyte precursor cell maturation (Bonfanti2020Abnormal).

GPR17's interaction with chemokine receptors, such as CXCR2 and CXCR4, may influence inflammatory processes and the chronicization of acute inflammatory events, particularly in demyelinating diseases like MS (Daniele2022Functional). These interactions highlight GPR17 as a potential pharmacological target for therapeutic interventions in both metabolic and neurological disorders.

## Interactions
GPR17, a G protein-coupled receptor, engages in various physical interactions with other proteins, influencing its cellular functions. It interacts with SNX27, a member of the retromer complex, through its PDZ-binding motif. This interaction is crucial for the endocytic trafficking and recycling of GPR17 to the plasma membrane. Mutations in the PDZ-binding motif or SNX27 knockdown result in GPR17 retention in endocytic vesicles, highlighting SNX27's role in GPR17 stability and recycling (Meraviglia2016SNX27).

GPR17 also forms heterodimers with chemokine receptors CXCR2 and CXCR4. These interactions are modulated by specific agonists and antagonists, affecting intracellular signaling pathways such as cAMP modulation. GPR17 and CXCR2 can influence each other's functionality, while CXCR4 can affect GPR17 functionality but not vice versa. These interactions may play a role in neuroinflammatory processes associated with demyelinating events (Daniele2022Functional).

Additionally, GPR17 recruits β-arrestin2 in an agonist-dependent manner, which may regulate its functional responsiveness and facilitate its removal from the plasma membrane. This recruitment is linked to the phosphorylation of ERK1/2, a process primarily dependent on G protein signaling (Hennen2013Decoding).


## References


[1. (Pugliese2009Functional) Anna Maria Pugliese, Maria Letizia Trincavelli, Davide Lecca, Elisabetta Coppi, Marta Fumagalli, Silvia Ferrario, Paola Failli, Simona Daniele, Claudia Martini, Felicita Pedata, and Maria P. Abbracchio. Functional characterization of two isoforms of the p2y-like receptor gpr17: [35s]gtpγs binding and electrophysiological studies in 1321n1 cells. American Journal of Physiology-Cell Physiology, 297(4):C1028–C1040, October 2009. URL: http://dx.doi.org/10.1152/ajpcell.00658.2008, doi:10.1152/ajpcell.00658.2008. This article has 47 citations.](https://doi.org/10.1152/ajpcell.00658.2008)

[2. (Daniele2022Functional) Simona Daniele, Simona Saporiti, Stefano Capaldi, Deborah Pietrobono, Lara Russo, Uliano Guerrini, Tommaso Laurenzi, Elham Ataie Kachoie, Luca Palazzolo, Vincenzo Russo, Maria Pia Abbracchio, Ivano Eberini, and Maria Letizia Trincavelli. Functional heterodimerization between the g protein-coupled receptor gpr17 and the chemokine receptors 2 and 4: new evidence. International Journal of Molecular Sciences, 24(1):261, December 2022. URL: http://dx.doi.org/10.3390/ijms24010261, doi:10.3390/ijms24010261. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24010261)

[3. (Conley2021Human) Jason M. Conley, Hongmao Sun, Kristin L. Ayers, Hu Zhu, Rong Chen, Min Shen, Matthew D. Hall, and Hongxia Ren. Human gpr17 missense variants identified in metabolic disease patients have distinct downstream signaling profiles. Journal of Biological Chemistry, 297(1):100881, July 2021. URL: http://dx.doi.org/10.1016/j.jbc.2021.100881, doi:10.1016/j.jbc.2021.100881. This article has 3 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jbc.2021.100881)

[4. (Hennen2013Decoding) Stephanie Hennen, Haibo Wang, Lucas Peters, Nicole Merten, Katharina Simon, Andreas Spinrath, Stefanie Blättermann, Rhalid Akkari, Ramona Schrage, Ralf Schröder, Daniel Schulz, Celine Vermeiren, Katrin Zimmermann, Stefan Kehraus, Christel Drewke, Alexander Pfeifer, Gabriele M. König, Klaus Mohr, Michel Gillard, Christa E. Müller, Q. Richard Lu, Jesus Gomeza, and Evi Kostenis. Decoding signaling and function of the orphan g protein–coupled receptor gpr17 with a small-molecule agonist. Science Signaling, October 2013. URL: http://dx.doi.org/10.1126/scisignal.2004350, doi:10.1126/scisignal.2004350. This article has 110 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1126/scisignal.2004350)

[5. (Bonfanti2020Abnormal) Elisabetta Bonfanti, Tiziana Bonifacino, Stefano Raffaele, Marco Milanese, Erica Morgante, Giambattista Bonanno, Maria P. Abbracchio, and Marta Fumagalli. Abnormal upregulation of gpr17 receptor contributes to oligodendrocyte dysfunction in sod1 g93a mice. International Journal of Molecular Sciences, 21(7):2395, March 2020. URL: http://dx.doi.org/10.3390/ijms21072395, doi:10.3390/ijms21072395. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms21072395)

[6. (Fumagalli2017Pharmacological) Marta Fumagalli, Davide Lecca, Giusy T. Coppolino, Chiara Parravicini, and Maria P. Abbracchio. Pharmacological Properties and Biological Functions of the GPR17 Receptor, a Potential Target for Neuro-Regenerative Medicine, pages 169–192. Springer Singapore, 2017. URL: http://dx.doi.org/10.1007/5584_2017_92, doi:10.1007/5584_2017_92. This article has 27 citations.](https://doi.org/10.1007/5584_2017_92)

[7. (Chen2009The) Ying Chen, Heng Wu, Shuzong Wang, Hisami Koito, Jianrong Li, Feng Ye, Jenny Hoang, Sabine S Escobar, Alexander Gow, Heather A Arnett, Bruce D Trapp, Nitin J Karandikar, Jenny Hsieh, and Q Richard Lu. The oligodendrocyte-specific g protein–coupled receptor gpr17 is a cell-intrinsic timer of myelination. Nature Neuroscience, 12(11):1398–1406, October 2009. URL: http://dx.doi.org/10.1038/nn.2410, doi:10.1038/nn.2410. This article has 274 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nn.2410)

[8. (Saravanan2018Identification) Konda Mani Saravanan, Suresh Palanivel, Olli Yli-Harja, and Meenakshisundaram Kandhavelu. Identification of novel gpr17-agonists by structural bioinformatics and signaling activation. International Journal of Biological Macromolecules, 106:901–907, January 2018. URL: http://dx.doi.org/10.1016/j.ijbiomac.2017.08.088, doi:10.1016/j.ijbiomac.2017.08.088. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ijbiomac.2017.08.088)

[9. (Lecca2020Regulation) Davide Lecca, Stefano Raffaele, Maria P. Abbracchio, and Marta Fumagalli. Regulation and signaling of the gpr17 receptor in oligodendroglial cells. Glia, 68(10):1957–1967, February 2020. URL: http://dx.doi.org/10.1002/glia.23807, doi:10.1002/glia.23807. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/glia.23807)

[10. (Yang2020FLIM–FRETBased) Ju Yang, Zhou Gong, Yun-Bi Lu, Chan-Juan Xu, Tao-Feng Wei, Meng-Shi Yang, Tian-Wei Zhan, Yu-Hong Yang, Li Lin, Jianfeng Liu, Chun Tang, and Wei-Ping Zhang. Flim–fret-based structural characterization of a class-a gpcr dimer in the cell membrane. Journal of Molecular Biology, 432(16):4596–4611, July 2020. URL: http://dx.doi.org/10.1016/j.jmb.2020.06.009, doi:10.1016/j.jmb.2020.06.009. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2020.06.009)

[11. (Meraviglia2016SNX27) Veronica Meraviglia, Alessandro Francesco Ulivi, Marta Boccazzi, Fabiola Valenza, Alessandra Fratangeli, Maria Passafaro, Davide Lecca, Fiorenza Stagni, Andrea Giacomini, Renata Bartesaghi, Maria P. Abbracchio, Stefania Ceruti, and Patrizia Rosa. Snx27, a protein involved in down syndrome, regulates gpr17 trafficking and oligodendrocyte differentiation. Glia, 64(8):1437–1460, June 2016. URL: http://dx.doi.org/10.1002/glia.23015, doi:10.1002/glia.23015. This article has 18 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/glia.23015)